BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 5933915)

  • 21. [Wilson's disease. Hepatic manifestations].
    Oliveira e Silva A; Roldan Molina LF; dos Santos TE; Santo GC; Gama-Rodrigues JJ; D'Albuquerque LA
    Arq Gastroenterol; 1989; 26(3):47-9. PubMed ID: 2697201
    [No Abstract]   [Full Text] [Related]  

  • 22. Copper and taste sensitivity.
    Nutr Rev; 1968 Jun; 26(6):175-7. PubMed ID: 4874926
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral zinc therapy for Wilson's disease.
    Nutr Rev; 1984 May; 42(5):184-6. PubMed ID: 6377131
    [No Abstract]   [Full Text] [Related]  

  • 24. The copper-controlled diet: current aspects of dietary copper restriction in management of copper metabolism disorders.
    Smithgall JM
    J Am Diet Assoc; 1985 May; 85(5):609-10. PubMed ID: 3886765
    [No Abstract]   [Full Text] [Related]  

  • 25. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs].
    Szczepanski A
    Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035
    [No Abstract]   [Full Text] [Related]  

  • 26. Introduction. Symposium on copper metabolism and Wilson's disease.
    Goldstein NP; Owen CA
    Mayo Clin Proc; 1974 Jun; 49(6):363-7. PubMed ID: 4599351
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatolenticular degeneration: biochemical and therapeutic considerations].
    Clin Ter; 1976 Mar; 76(6):567-76. PubMed ID: 828082
    [No Abstract]   [Full Text] [Related]  

  • 28. Wilson's disease: an update, with emphasis on new approaches to treatment.
    Brewer GJ; Yuzbasiyan-Gurkan V
    Dig Dis; 1989; 7(4):178-93. PubMed ID: 2663256
    [No Abstract]   [Full Text] [Related]  

  • 29. Some problems of the penicillamine action in hepatolenticular degeneration.
    Chromy K; Heyrovsky A
    Metabolism; 1966 Jun; 15(6):529-36. PubMed ID: 5933915
    [No Abstract]   [Full Text] [Related]  

  • 30. The physiology of copper in man and its relation to Wilson's disease.
    Walshe JM
    Brain; 1967 Mar; 90(1):149-76. PubMed ID: 5336999
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of Wilson's disease.
    Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
    Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic use of d-penicillamine].
    Bogdanikowa B
    Pol Tyg Lek; 1972 Oct; 27(41):1612-3. PubMed ID: 4581541
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatolenticular degeneration. Wilson's disease].
    Hansen HJ; Andersen OS
    Ugeskr Laeger; 1969 Jul; 131(31):1301-5. PubMed ID: 4898805
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.